Caplight Logo









Fountain Life

Fountain Life

Private
Naples, FloridaHealthcare & Life Scienceshttps://www.fountainlife.com

Last Round

Series B

Aug 14, 2025

Total Funding Raised

$48M

Company Overview

Fountain Life is a preventative health and longevity company that aims to transform healthcare from reactive to proactive. It utilizes advanced diagnostics, such as full-body MRI, AI, and genomic testing, to detect illnesses like cancer, cardiac, and neurodegenerative diseases at their earliest stages before symptoms appear. The company operates on a membership model, offering personalized health plans and access to cutting-edge therapeutics to help members extend their healthspan and performance. Founded by Tony Robbins, Dr. Peter Diamandis, and Dr. Robert Hariri, Fountain Life operates a network of clinics across the US and globally, with plans for continued expansion.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Medical Imaging, Medical AI, InsurTech, Healthcare Analytics

Business Model

B2C

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

longevity clinicpreventative healthconcierge medicineAI diagnosticsfull body scanhealthspan optimizationliquid biopsyprecision medicinebiohackingearly disease detectionexecutive health programwhole genome sequencingcoronary CT angiographyCCTAregenerative therapiescorporate health insurancestem cell therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fountain Life Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Fountain Life Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BAug 14, 2025
Series ADec 15, 2022
Early FundingDec 15, 2022

Key People

Founding team and executive leadership

William Kapp

Chief Executive Officer

Executive Team

Shawn Buchheit

President Chief Operating Officer

Executive Team

Chris Hemp

Chief Technology Officer

Executive Team

Lauren Murphy

Chief Financial Officer

Executive Team

Fountain Life Investors

Notable investors and investment history

InvestorRounds
George-AustinSeries A
EOS VenturesSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    Serves 8,000 members, according to a job posting.

  • Dec 1, 2025

    Dr. Mussallem appointed Chief Medical Officer in December 2025.

Fountain Life Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Fountain Life Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Fountain Life's valuation, stock price, and market status.

Firmographic Details

HeadquartersNaples, Florida
Employee Range210
Year Founded2020
Last FundingAug 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.